| DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology VT DeVita, TS Lawrence, SA Rosenberg Lippincott Williams & Wilkins, 2008 | 7513* | 2008 |
| Cancer regression in patients after transfer of genetically engineered lymphocytes RA Morgan, ME Dudley, JR Wunderlich, MS Hughes, JC Yang, ... Science 314 (5796), 126-129, 2006 | 4107 | 2006 |
| Cancer immunotherapy: moving beyond current vaccines SA Rosenberg, JC Yang, NP Restifo Nature medicine 10 (9), 909-915, 2004 | 3764 | 2004 |
| Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes ME Dudley, JR Wunderlich, PF Robbins, JC Yang, P Hwu, ... Science 298 (5594), 850-854, 2002 | 3727 | 2002 |
| A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone SA Rosenberg, MT Lotze, LM Muul, AE Chang, FP Avis, S Leitman, ... New England Journal of Medicine 316 (15), 889-897, 1987 | 3626 | 1987 |
| A randomized trial of bevacizumab, an anti–vascular endothelial growth factor antibody, for metastatic renal cancer JC Yang, L Haworth, RM Sherry, P Hwu, DJ Schwartzentruber, ... New England Journal of Medicine 349 (5), 427-434, 2003 | 3566 | 2003 |
| Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer SA Rosenberg, MT Lotze, LM Muul, S Leitman, AE Chang, ... New England journal of medicine 313 (23), 1485-1492, 1985 | 3443 | 1985 |
| T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial DW Lee, JN Kochenderfer, M Stetler-Stevenson, YK Cui, C Delbrook, ... The Lancet 385 (9967), 517-528, 2015 | 3124 | 2015 |
| Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma SA Rosenberg, BS Packard, PM Aebersold, D Solomon, SL Topalian, ... New England Journal of Medicine 319 (25), 1676-1680, 1988 | 3074 | 1988 |
| Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 RA Morgan, JC Yang, M Kitano, ME Dudley, CM Laurencot, ... Molecular therapy 18 (4), 843-851, 2010 | 2816 | 2010 |
| Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy SA Rosenberg, JC Yang, RM Sherry, US Kammula, MS Hughes, ... Clinical cancer research 17 (13), 4550-4557, 2011 | 2606 | 2011 |
| A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes SA Rosenberg, P Spiess, R Lafreniere Science 233 (4770), 1318-1321, 1986 | 2556 | 1986 |
| Adoptive cell transfer as personalized immunotherapy for human cancer SA Rosenberg, NP Restifo Science 348 (6230), 62-68, 2015 | 2502 | 2015 |
| High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993 MB Atkins, MT Lotze, JP Dutcher, RI Fisher, G Weiss, K Margolin, ... Journal of clinical oncology 17 (7), 2105-2105, 1999 | 2459 | 1999 |
| Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer E Tran, S Turcotte, A Gros, PF Robbins, YC Lu, ME Dudley, ... Science 344 (6184), 641-645, 2014 | 2414 | 2014 |
| Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma SA Rosenberg, JC Yang, DJ Schwartzentruber, P Hwu, FM Marincola, ... Nature medicine 4 (3), 321-327, 1998 | 2235 | 1998 |
| T lymphocyte-directed gene therapy for ADA− SCID: initial trial results after 4 years RM Blaese, KW Culver, AD Miller, CS Carter, T Fleisher, M Clerici, ... Science 270 (5235), 475-480, 1995 | 2177 | 1995 |
| Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma ME Dudley, JR Wunderlich, JC Yang, RM Sherry, SL Topalian, NP Restifo, ... Journal of clinical oncology: official journal of the American Society of …, 2005 | 2117 | 2005 |
| Adoptive cell transfer: a clinical path to effective cancer immunotherapy SA Rosenberg, NP Restifo, JC Yang, RA Morgan, ME Dudley Nature Reviews Cancer 8 (4), 299-308, 2008 | 2085 | 2008 |
| Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired M Ahmadzadeh, LA Johnson, B Heemskerk, JR Wunderlich, ME Dudley, ... Blood, The Journal of the American Society of Hematology 114 (8), 1537-1544, 2009 | 2042 | 2009 |
